Weihe
Weihe Liu, Shenzhen City CN
Patent application number | Description | Published |
---|---|---|
20150196062 | BATTERY ASSEMBLY AND ELECTRONIC CIGARETTE HAVING SAME - An exemplary battery assembly for an electronic cigarette includes a housing, a battery received in the housing, and a first switch assembly connected to the battery. The first switch assembly includes a fixed electrode, and a rotatable electrode. The fixed electrode is connected to the battery. The fixed electrode has a conductive area and an insulated area. The rotatable electrode is rotatable between a first position and a second position. In the first position, the rotatable electrode is in contact with the conductive area, thus connecting to the fixed electrode, and the first switch assembly is turned on. In the second position, the rotatable electrode is positioned in the insulated area, thus disconnecting from the fixed electrode, and the first switch assembly is turned off. | 07-16-2015 |
Weihe Zhang, Vestavia, AL US
Patent application number | Description | Published |
---|---|---|
20150290194 | THERAPEUTIC USES OF SELECTED PYRIMIDINE COMPOUNDS WITH ANTI-MER TYROSINE KINASE ACTIVITY - Uses of pyrimidines with anti-Mer tyrosine kinase activity as anti-infective agents, immunostimulatory and immunomodulatory agents, anti-cancer agents (including against MerTK −/− tumors and ITD and TKD mutant forms of Acute Myeloid Leukemia (AML)), and as adjunctive agents in combination with chemotherapeutic, radiation or other standard of care for neoplasms. | 10-15-2015 |
20150290197 | THERAPEUTIC USES OF SELECTED PYRROLOPYRIMIDINE COMPOUNDS WITH ANTI-MER TYROSINE KINASE ACTIVITY - Uses of pyrrolopyrimidines with anti-Mer tyrosine kinase activity as anti-infective agents, immunostimulatory and immunomodulatory agents, anti-cancer agents (including against MerTK−/− tumors and ITD and TKD mutant forms of Acute Myeloid Leukemia (AML)), and as adjunctive agents in combination with chemotherapeutic, radiation or other standard of care for neoplasms. | 10-15-2015 |
20150291606 | MERTK-SPECIFIC PYRROLOPYRIMIDINE COMPOUNDS - The present invention includes pyrrolopyrimidine compounds that selectively inhibit Mer tyrosine kinase (MerTK) activity and/or Tyro3 tyrosine kinase activity, and use of these pyrrolopyrimidine compounds as anti-cancer agents, immunostimulatory and immunomodulatory agents, anti-platelet agents, anti-infective agents, and as adjunctive agents in combination with chemotherapeutic, radiation or other standard of care for neoplasms. | 10-15-2015 |
Weihe Zhaug, Chapel Hill, NC US
Patent application number | Description | Published |
---|---|---|
20130059836 | PYRAZOLOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER - Compound of Formula (I): are described, along with pharmaceutically acceptable salts thereof, compositions containing the same, and methods of use thereof in the treatment of cancer. | 03-07-2013 |